“Decreased bioavailability induced by simultaneous intake of other medications (eg, aluminum-containing antacids, iron , cholestyramine, sucralfate) is a well-known occurrence with levothyroxine therapy.1 Decreased absorption could similarly account for the calcium carbonate effect.”